A Cross-Sectional Survey of Pediatric Infectious Disease Physicians’ Approach to Congenital Cytomegalovirus Infection

Congenital cytomegalovirus (cCMV) continues to be a major public health care issue due to its high prevalence throughout the world. However, there is a paucity of studies evaluating how providers manage this infection. This study surveyed North American Pediatric Infectious Disease (PID) physicians to elicit their approach towards the evaluation and treatment of this condition. Thirty-two PID physicians responded to this survey. Institutional testing and screening for cCMV were infrequently reported. The respondents in general agreed upon most laboratory and diagnostic testing except for neuroimaging. For those tests, there was a disparity in indications for head ultrasound versus brain MRI imaging. Most (68.8%) agreed with the clinical practice of starting valganciclovir in an infant less than 1 month of age with one sign or symptom of disease, and 62.5% would do so for an infant with isolated sensorineural hearing loss. However, only 28.1% would treat cCMV-infected infants older than 1 month of age. In conclusion, few healthcare institutions represented by PID physicians in this cohort had a cCMV screening or testing initiative, yet most respondents would test at a much higher level based on their clinical practice. While there is general consensus in evaluation and treatment of these children, there are disparities in practices regarding neuroimaging and indications for antiviral treatment with respect to age and severity of disease. There is a great need for an evidence based policy statement to standardize cCMV workup and treatment.

[1]  A. Park,et al.  Analysis of an Expanded Targeted Early Cytomegalovirus Testing Program. , 2023, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[2]  Annelies Keymeulen,et al.  The Effect of (Val)ganciclovir on Hearing in Congenital Cytomegalovirus: A Systematic Review , 2022, The Laryngoscope.

[3]  K. Muldoon,et al.  Congenital Cytomegalovirus Knowledge, Practices, and Beliefs Among Primary Care Physicians and Newborn Hospitalists , 2022, Journal of primary care & community health.

[4]  S. Laroche,et al.  Cranial ultrasound and MRI: complementary or not in the diagnostic assessment of children with congenital CMV infection? , 2021, European Journal of Pediatrics.

[5]  J. Broach,et al.  Congenital Cytomegalovirus Infection Burden and Epidemiologic Risk Factors in Countries With Universal Screening , 2021, JAMA network open.

[6]  A. Park,et al.  A Cross-Sectional Survey Evaluating Awareness of Congenital Cytomegalovirus Among Audiologists and Speech-Language Pathologists. , 2021, American journal of audiology.

[7]  J. Bale,et al.  Brain Magnetic Resonance Imaging in Congenital Cytomegalovirus With Failed Newborn Hearing Screen. , 2020, Pediatric neurology.

[8]  A. Park,et al.  Should hearing targeted screening for congenital cytomegalovirus infection Be implemented? , 2020, International journal of pediatric otorhinolaryngology.

[9]  T. Greene,et al.  Should You Follow the Better-Hearing Ear for Congenital Cytomegalovirus Infection and Isolated Sensorineural Hearing Loss? , 2020, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[10]  B. Tapiéro,et al.  Head ultrasound, CT or MRI? The choice of neuroimaging in the assessment of infants with congenital cytomegalovirus infection , 2019, BMC Pediatrics.

[11]  Nancy L. Murray,et al.  Congenital Cytomegalovirus and Hearing Loss: A Pilot Cross-Sectional Survey of Otologists’ and Pediatric Otolaryngologists’ Knowledge , 2019, OTO open.

[12]  S. Boppana,et al.  The Burden of Congenital Cytomegalovirus Infection: A Prospective Cohort Study of 20 000 Infants in Finland. , 2019, Journal of the Pediatric Infectious Diseases Society.

[13]  E. Bilavsky,et al.  Valganciclovir Is Beneficial in Children with Congenital Cytomegalovirus and Isolated Hearing Loss , 2018, The Journal of pediatrics.

[14]  D. Kimberlin,et al.  Closer to Universal Newborn Screening for Congenital Cytomegalovirus Infection but Far Away from Antiviral Therapy in All Infected Infants. , 2018, The Journal of pediatrics.

[15]  D. Bernstein,et al.  Contribution of Breastfeeding to False-Positive Saliva Polymerase Chain Reaction for Newborn Congenital Cytomegalovirus Screening , 2018, The Journal of infectious diseases.

[16]  N. Klein,et al.  Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management , 2017, The Pediatric infectious disease journal.

[17]  K. Muldoon,et al.  Knowledge of congenital cytomegalovirus (cCMV) among physical and occupational therapists in the United States , 2017, PloS one.

[18]  Wendy J M van Zuylen,et al.  Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. , 2017, The Lancet. Infectious diseases.

[19]  G. Demmler-Harrison,et al.  Hearing Loss in Children With Asymptomatic Congenital Cytomegalovirus Infection , 2017, Pediatrics.

[20]  A. Park,et al.  Outcomes From a Hearing-Targeted Cytomegalovirus Screening Program , 2017, Pediatrics.

[21]  F. Dionne,et al.  Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection. , 2016, JAMA pediatrics.

[22]  J. Pardo,et al.  Hearing outcome of infants with congenital cytomegalovirus and hearing impairment , 2016, Archives of Disease in Childhood.

[23]  R. DeBiasi,et al.  Valganciclovir for symptomatic congenital cytomegalovirus disease. , 2015, The New England journal of medicine.

[24]  I. Dhooge,et al.  Hearing Loss and Congenital CMV Infection: A Systematic Review , 2014, Pediatrics.

[25]  S. Grosse,et al.  Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[26]  W. Britt,et al.  Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection. , 2014, The Journal of pediatrics.

[27]  T. Lazzarotto,et al.  Role of cerebral ultrasound and magnetic resonance imaging in newborns with congenital cytomegalovirus infection , 2014, Brain and Development.

[28]  R. Raggam,et al.  Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up. , 2009, The Journal of laryngology and otology.

[29]  M. Cannon,et al.  Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infection , 2007, Reviews in medical virology.

[30]  S. Soong,et al.  Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. , 2003, The Journal of pediatrics.